{
    "matched_specifications": [
        [
            "hiv incidence",
            "1.32%"
        ],
        [
            "hiv incidence",
            "0.66%"
        ],
        [
            "hiv incidence",
            "1.82%"
        ]
    ],
    "unmatched_specifications": [
        [
            "study design",
            "itt analysis"
        ],
        [
            "analysis type",
            "cabotegravir effectiveness"
        ],
        [
            "subgroup",
            "contraceptive method"
        ],
        [
            "sub-subgroup",
            "implant"
        ],
        [
            "group",
            "tdf-ftc"
        ],
        [
            "events",
            "8"
        ],
        [
            "total person-years",
            "607"
        ],
        [
            "study design",
            "itt analysis"
        ],
        [
            "analysis type",
            "cabotegravir effectiveness"
        ],
        [
            "subgroup",
            "contraceptive method"
        ],
        [
            "sub-subgroup",
            "other"
        ],
        [
            "group",
            "tdf-ftc"
        ],
        [
            "events",
            "1"
        ],
        [
            "total person-years",
            "152"
        ],
        [
            "study design",
            "itt analysis"
        ],
        [
            "analysis type",
            "cabotegravir effectiveness"
        ],
        [
            "subgroup",
            "body-mass index"
        ],
        [
            "sub-subgroup",
            ">30 kg/m\u00b2"
        ],
        [
            "group",
            "tdf-ftc"
        ],
        [
            "events",
            "9"
        ],
        [
            "total person-years",
            "495"
        ]
    ],
    "unmatched_extracted_keys": [
        "study design",
        "sub-subgroup",
        "group",
        "total person-years",
        "analysis type"
    ],
    "unmatched_extracted_values": [
        "contraceptive method",
        "152",
        "body-mass index",
        "495",
        "9",
        "8",
        "cabotegravir effectiveness",
        "itt analysis",
        "tdf-ftc",
        "607",
        "1"
    ],
    "unmatched_ground_truth_keys": [
        "method"
    ],
    "unmatched_ground_truth_values": [
        "0",
        "firth's method used due to zero infections in cabotegravir group"
    ],
    "mapped_keys": {
        "subgroup": "subgroup",
        "events": "events per total py in tdf-ftc group",
        "hiv incidence": "events per total py in cabotegravir group"
    },
    "mapped_values": {
        "implant": "implant contraceptive method",
        "1.32%": "8/607 (1.32%)",
        "other": "other contraceptive method",
        "0.66%": "1/152 (0.66%)",
        ">30 kg/m\u00b2": "bmi >30 kg/m\u00b2",
        "1.82%": "9/495 (1.82%)"
    },
    "precision": 0.125,
    "recall": 0.25
}